Do the effects of APOE-ε4 on cognitive function and decline depend upon vitamin status? MacArthur Studies of Successful Aging (Q43506122)

24 November 2017

Do the effects of APOE-ε4 on cognitive function and decline depend upon vitamin status? MacArthur Studies of Successful Aging (English)

1 reference

24 November 2017

4

T Seeman

1 reference

24 November 2017

B Brown

1

1 reference

24 November 2017

M H Huang

series ordinal

2

1 reference

24 November 2017

A Karlamangla

series ordinal

3

1 reference

24 November 2017

D Kado

series ordinal

5

1 reference

24 November 2017

1 March 2011

1 reference

The Journal of Nutrition, Health and Aging

24 November 2017

1 reference

24 November 2017

15

1 reference

24 November 2017

3

1 reference

24 November 2017

196-201

1 reference

https://scigraph.springernature.com/pub.10.1007/s12603-010-0277-5

24 November 2017

0 references

cites work

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Functional vitamin B(12) deficiency and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Homocysteine-lowering B vitamin therapy in cardiovascular prevention--wrong again?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Utilization of cognitive support in episodic free recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Apolipoprotein E, B vitamins, and cognitive function in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Homocysteine and cognitive function in a population-based study of older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Homocysteine and cognitive performance: modification by the ApoE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Homocysteine, white matter hyperintensities, and cognition in healthy elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Education and APOE-e4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Homocysteine levels and decline in physical function: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Cognitive performance in a high-functioning community-dwelling elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

No adjustments are needed for multiple comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Total serum homocysteine in senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0277-5

Total homocysteine in plasma or serum: methods and clinical applications

21 January 2018

1 reference

12 December 2020

Radioenzymatic assay for direct measurement of plasma pyridoxal 5'-phosphate

1 reference

12 December 2020

Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

Cognitive activity in older persons from a geographically defined population

1 reference

12 December 2020

Inhibition of EDTA of growth of Lactobacillus casei in the folate microbiological assay and its reversal by added manganese or iron

1 reference

12 December 2020

10.1007/S12603-010-0277-5

Identifiers

DOI

1 reference

24 November 2017

1 reference